Literature DB >> 2045164

Central effect of endothelin on neurohormonal responses in conscious rabbits.

K Matsumura1, I Abe, T Tsuchihashi, M Tominaga, K Kobayashi, M Fujishima.   

Abstract

It has been shown that endothelin-1 (ET-1) binding sites exist in the central nervous system and that the injection of intracerebroventricular ET-1 induces a pressor response. Therefore, we determined the neurohormonal and cardiovascular responses to intracerebroventricular ET-1 (25 pmol/kg) in conscious rabbits with chronically instrumented electrodes on the renal sympathetic nerve. Intracerebroventricular ET-1 provoked a prompt increase in arterial pressure and in renal sympathetic nerve activity within 5 minutes, and peak values were obtained at 20 and 40 minutes, respectively. Plasma epinephrine and norepinephrine reached peak values at 5-20 minutes. Plasma vasopressin and plasma glucose levels also increased significantly, but plasma osmolality, hematocrit, and serum sodium and potassium concentrations did not show any changes. Arterial blood gas analysis showed respiratory alkalosis. However, pretreatment with intravenous pentolinium (5 mg/kg), a ganglion blocking agent, abolished these neurohormonal and cardiovascular responses. Conversely, the same dose of intravenous ET-1 (25 pmol/kg) as that used in the intracerebroventricular experiment failed to cause any cardiovascular or renal sympathetic nerve responses. These results suggest that intracerebroventricular ET-1 acts in the central nervous system and causes a pressor response mainly through the enhancement of sympathoadrenal outflow.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2045164     DOI: 10.1161/01.hyp.17.6.1192

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  5 in total

Review 1.  Regulation of blood pressure and salt homeostasis by endothelin.

Authors:  Donald E Kohan; Noreen F Rossi; Edward W Inscho; David M Pollock
Journal:  Physiol Rev       Date:  2011-01       Impact factor: 37.312

2.  Pharmacokinetics and pharmacodynamic effects of ABT-627, an oral ETA selective endothelin antagonist, in humans.

Authors:  M C Verhaar; A Y Grahn; A W Van Weerdt; M L Honing; P J Morrison; Y P Yang; R J Padley; T J Rabelink
Journal:  Br J Clin Pharmacol       Date:  2000-06       Impact factor: 4.335

3.  RNAi silencing of brain klotho potentiates cold-induced elevation of blood pressure via the endothelin pathway.

Authors:  Xiuqing Wang; Zhongjie Sun
Journal:  Physiol Genomics       Date:  2010-01-19       Impact factor: 3.107

4.  Metabolic and neuroanatomical correlates of barrel-rolling and oculoclonic convulsions induced by intraventricular endothelin-1: a novel peptidergic signaling mechanism in visuovestibular and oculomotor regulation?

Authors:  P M Gross; R J Beninger; S W Shaver; D S Wainman; F J Espinosa; D F Weaver
Journal:  Exp Brain Res       Date:  1993       Impact factor: 1.972

5.  Targeted over-expression of endothelin-1 in astrocytes leads to more severe brain damage and vasospasm after subarachnoid hemorrhage.

Authors:  Patrick K K Yeung; Jiangang Shen; Stephen S M Chung; Sookja K Chung
Journal:  BMC Neurosci       Date:  2013-10-25       Impact factor: 3.288

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.